Performance of Newly Listed Shares as on 18th September

Name Date of Listing Issue Price Closing Price Closing Price % Gain Loss % Change Over
      180920 110920 Over Week lssue Price
Polycab India Limited 16th April 538.00 877.30 847.40 3.53 63.07
Neogen Chemical Limited 8th May 215.00 701.00 706.00 -0.71 226.05
Indiamart Intermesh Limited 4th July 973.00 5005.90 4768.20 4.99 414.48
Affle (India) Limited 8th August 745.00 3034.10 2907.45 4.36 307.26
Spandana Sphoorty Financial Ltd 19th August 856.00 569.25 579.05 -1.69 -33.50
Sterling & Wilson Solar Ltd 20th August 780.00 219.65 269.15 -18.39 -71.84
IRCTC Limited 14th October 320.00 1403.85 1370.50 2.43 338.70
Vishwaraj Sugar Industries Limited 15th October 60.00 96.00 92.80 3.45 60.00
CSB Bank Limited 4th December 195.00 223.55 226.10 -1.13 14.64
Ujjivan Small Finance Bank Limited 12th December 37.00 34.30 34.25 0.15 -7.30
Prince Pipes and Fittings Limited 30th December 178.00 225.80 204.05 10.66 26.85
SBI Card &Payment Services Limited 16th March 755.00 845.10 849.45 -0.51 11.93
Rossari Biotech Limited 23rd July 425.00 825.85 781.00 5.74 94.32
Mindspace Buisness Parks Reit 7th July 275.00 301.10 302.20 -0.36 9.49
Happiest Mind Technologies Ltd 17th September 166.00 358.45 NA 115.93 115.93

Happiest Mind Technologies Limited – Debuts With Gains Of Over 123%

Happiest Mind Technologies Limited, a company promoted by Ashok Soota, formerly of Mindtree had a dream debut when its shares listed on Friday the 17th of September. Shares which were issued in a price band of Rs 165-166, debuted at Rs 350 and closed at Rs 371, a gain of Rs 205 or 123.49%.

The company had entered the capital markets with its fresh issue of Rs 110 crs and an offer for sale of 3.566 cr shares. The issue had opened on Monday the 7th of September and closed on Wednesday the 9th of September.

The company allotted 1,90,30,541 equity shares to 25 Anchor investors comprising of 38 entities. The highest allocation of 10,84,320 equity shares was made to Government of Singapore. This amounts to 5.70% of the issue size. The next highest allocation was made to 13 investors who have each been allotted 9,63,810 shares or 5.06% of the anchor allocation.

The issue size was roughly Rs 702 crs from the fresh issue and offer for sale components combined. The company had offered shares at a PE multiple of 30.8 to 31 times its diluted earnings of Rs 5.36 for the year ended March 2020.

The discovered price on BSE was Rs 351 while it was Rs 350 on NSE. The traded volume on BSE at the discovered price was Rs 2.82 lac shares while it was 57.75 lac shares at NSE. The opening prices were the day’s low on both the exchanges. The high of the day was Rs 395 on BSE while it was Rs 394.95 on NSE. The close of the day was Rs 371 on BSE, a gain of Rs 205 or 123.49%, while it was Rs 370.95 or 123.46% on NSE. The weighted average of the day’s trade was Rs 375.26 on BSE and Rs 373.27 on NSE.

Exchange Open High Low Close Net Change % Gain/ Loss Wt.Avg Volume Delivery Del %age
BSE 351.00 395.00 351.00 371.00 205.00 123.49 375.26 10973257 2990015/td>

27.25
NSE 350.00 394.95 350.00 370.95 204.95 123.46 373.27 48410702 18640107 38.50
Total 59383959 21630122 36.42

The traded volume on BSE was 109.73 lacs while it was 484.10 lacs on NSE making a total of 593.83 lac shares. This total traded volume was 1.4 times the IPO size of 422.9 lac shares and 2.55 times the non-anchor portion of 232.95 lac shares. Delivery volume on the two exchanges combined was 216.30 lac shares which was 36.42% of the traded volume. It was 51.15% of the IPO size and 92.99% of the non-anchor portion. This number is very significant and implies that almost everybody who was allotted shares in the IPO irrespective of whether he was in the QIB, HNI or Retail category has virtually sold out. There was just one buyer whose name was mentioned in the bulk trades category. Plutus Wealth Management LLP bought 10 lac shares at the discovered price of Rs 350 on NSE.

This has happened after the issue of Rossari Biotech where there was a similar delivery percentage. Whether this is a new normal or the trend one will have to see in some more issues before deciding.

The share has done better than expected and beaten all possible expectations. Good show and let us see what the share has in store for us going forward.

Market Rally Has Become Skewed – Time to Be Cautious

The week gone by saw markets jump sharply on Thursday and the gains registered on that day were enough to keep indices in positive territory. BSESENSEX gained 497.37 points or 1.30% to close at 38.854.55 points while NIFTY gained 130.60 points or 1.15% to close at 11,464.45 points. The broader markets saw BSE100, BSE200 and BSE500 gain 1.07%, 0.91% and 0.77% respectively. BSEMIDCAP lost 1.06% while BSESMALLCAP was down 0.31%.

The Indian rupee lost 40 paisa or 0.55% to close at Rs 73.54 to the US Dollar. Dow Jones was under pressure and lost 467.67 points or 1.66% to close at 27,665.64 points.

Markets last week were a mixed bag and the final weekly outcome is certainly not reflected in the numbers. While indices were up between 1.15% and 1.30% the benchmark indices components were largely down. Reliance Industries was the notable exception gaining a massive Rs 242 or 11.65%. This translates to roughly 1.4-1.5 times the weekly gains on the SENSEX and NIFTY. Bulk of the gains in Reliance came on Thursday when the stock gained Rs 154 and SENSEX was up by 647 points. The important news for Reliance was the investment by Silver Lake of Rs 7,500 crs to buy 1.75% in RRVL (Reliance Retail Ventures Limited) valuing the company at Rs 4.21 lac crs. This also made the market cap of Reliance Industries to cross 200 billion dollars, making it the first Indian company to do so.

The two primary market offerings which opened and closed during the week had a fantastic response and showed that retail investors are more than willing to invest in the primary market. The first issue from Happiest Mind Technologies Limited saw the issue overall getting subscribed 150.98 times. The QIB portion was subscribed 77.43 times, HNI portion 351.46 times and Retail portion 70.94 times. The price band was Rs 165-166. The issue consisted of a fresh offer of Rs 110 crs and an offer for sale of 3.55 cr shares. There were over 22 lac applications in the issue.

The second issue during the week was from Route Mobile Limited and was subscribed 74.36 times. The QIB portion was subscribed 91.06 times, HNI portion 195.61 times, Retail portion was subscribed 12.85 times. The price band was Rs 345-350. The issue comprised of a fresh issue of Rs 240 crs and an offer for sale of Rs 360 crs.

SEBI has come out with a fresh set of guidelines for mutual funds who run multi-cap funds. These guidelines are to be effective by end January 2021 and would change the way these funds/schemes are run. These guidelines are quite contrary to what was specified when they came out with guidelines for funds some two years ago. The new guidelines state that any Multicap fund would have to invest a minimum of 25% in each of the three categories of stocks namely large cap, mid cap and small cap. At present the corpus of all the Multicap funds run by various mutual funds is Rs 1.47 lacs or say Rs 1.50 lacs for discussion purposes. This implies that they would have to invest Rs 37.5 k in midcap and Smallcap each. The largest fund in Multicap is Kotak at 29,714 crs. The present break up is 28% or Rs 8.3k in midcap and a mere 0.30% or Rs 90 crs in Smallcap. This implies that a sum of Rs 6,200 crs would have to be invested in Smallcap stocks. The largest Smallcap fund in the country is again from Kotak and has a total AUM of Rs 1,700 crs. Imagine investing Rs 37,500 crs collectively in small cap stocks cumulatively. This is easier said than done as the definition of Smallcap begins at serial number 251 of market capitalisation which based on six months average ending June 2020, shows the stock market capitalisation at Rs 6,955 crs. The 500th stock has a market cap of Rs 1,695 crs while the 1000th stock is at Rs 313 crs. The 3000th stock comes in at Rs 10 crs. This implies that there is virtually no depth in the small cap category.

Since informing the guidelines, SEBI has come out with a clarification on Sunday and allowed the renaming and merger of funds. This automatically assumes the consent to be taken and fun managers would prefer the easier way out of calling the funds as large cap or large and midcap. The concept of Multicap would certainly not remain considering the hardships that Smallcap stock selection would entail.

The first thing that comes to mind is that Smallcap stocks would have a field day at the bourses. This would be incorrect as schemes of mutual funds would have to write to unit holders and ask for consent to change the system of fund allocation. They would also have to offer a no-load exit to those not willing to continue. With there being hardly any liquidity in the Smallcap segment, it would be impractical to expect this scheme from SEBI to become successful. Fund managers would ask for the scheme to be fine-tuned at least as far as small cap is concerned.

On the covid-19 front, the number of patients globally has increased to 291,80,905 people with 928,265 deaths and 210,26,776 people recovering. In India the number of affected people has risen to 48,45,003 people with 79,754 deaths and 37,77,044 people having recovered. Compared to the previous week globally there were 18,90,374 new patients, 40,711 deaths and 16,52,641 people having recovered. In India, there were 6,42,441 new patients, 8,067 deaths, and 5,29,747 people recovering.

Coming to the week ahead in markets expect volatility to increase. While there could be some movement in small and midcap stocks on account of SEBI changes for mutual funds, they would be unsustainable as there is still time for their implementation. Mutual funds would ask for more time to implement and the bifurcation may see more changes as the 25% for Smallcap looks impractical. Secondly that the rally last week was more based on a singular stock Reliance, is certainly not comforting. If the rally is to sustain the same has to become broad-based, it cannot be so narrow. The strategy for the week would be to sell on rallies and wait for markets to correct before initiating fresh purchases.

Subscribe to RSS Feed Follow me on Twitter!